Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)
Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)

Author:

Publisher: World Health Organization

Published: 2021-05-17

Total Pages: 48

ISBN-13: 9240021345

DOWNLOAD EBOOK

The Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) aims to strengthen sentinel surveillance for gonococcal antimicrobial resistance (AMR) in selected countries. EGASP monitors trends in antimicrobial susceptibility in Neisseria gonorrhoeae by using standardized sampling and laboratory protocols linked to epidemiological data in participating countries. EGASP contributes to the WHO global action plan on antimicrobial resistance, 2015. EGASP is a special project under the Global Antimicrobial Resistance Surveillance System (GLASS). EGASP is a collaborative effort between the WHO, the United States Centers for Disease Control and Prevention (CDC) and WHO collaborating centres on STIs. The protocol document describes the objectives and the methods of EGASP surveillance and guidance on how to implement and monitor EGASP. This publication targets the national sexually transmitted infection and antimicrobial resistance programmes and other institutions to strengthen gonorrhoea AMR surveillance system. This surveillance protocol allows collaborators to improve the quality, comparability and timeliness of gonococcal antimicrobial resistance data across multiple countries. It also aims to enhance the capacity for early detection of emergence of resistance in N. gonorrhoeae strains to recommended treatment.

Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)
Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)

Author: World Health Organization

Publisher: World Health Organization

Published: 2024-02-02

Total Pages: 47

ISBN-13: 9240088520

DOWNLOAD EBOOK

The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) was developed to address many of GASP’s limitations and strengthen sentinel surveillance for gonococcal AMR in selected countries. EGASP is a unique project implemented under the EGASP protocol published in 2021 for participating countries to adapt to their context. It is aligned with the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS). The current report presents the main results of EGASP surveillance from November 2015 to December 2022.

Global antimicrobial resistance and use surveillance system (GLASS) report 2022
Global antimicrobial resistance and use surveillance system (GLASS) report 2022

Author: World Health Organization

Publisher: World Health Organization

Published: 2022-12-08

Total Pages: 82

ISBN-13: 924006270X

DOWNLOAD EBOOK

The WHO 2022 report from the Global Antimicrobial Resistance and Use Surveillance System (GLASS) marks the end of the first 5 years of early implementation. The report summarizes 2020 data from 87 countries on antimicrobial resistance (AMR) in bacteria that cause disease in humans, analyses the 2021 AMR rates in the context of the testing coverage of national surveillance, and provides data on antimicrobial consumption (AMC) in humans from 27 countries. For the first time, data are presented in an interactive digital format, with more comprehensive content on the WHO website.

GLASS manual for antimicrobial resistance surveillance in common bacteria causing human infection
GLASS manual for antimicrobial resistance surveillance in common bacteria causing human infection

Author: World Health Organization

Publisher: World Health Organization

Published: 2023-08-31

Total Pages: 72

ISBN-13: 9240076603

DOWNLOAD EBOOK

The purpose of this manual is to provide guidance for countries on the methods and metrics for the surveillance of AMR in selected bacteria causing common human infections. This manual is part of a package of documents and tools designed to inform GLASS implementation and describes the objectives and methodology of GLASS AMR, the GLASS component dealing with the global surveillance of AMR in selected bacteria causing common human infections.

Global antimicrobial resistance and use surveillance system (GLASS) report 2021
Global antimicrobial resistance and use surveillance system (GLASS) report 2021

Author:

Publisher: World Health Organization

Published: 2021-06-08

Total Pages: 180

ISBN-13: 9240027335

DOWNLOAD EBOOK

The GLASS Report 2021 highlights the new GLASS technical module on antimicrobial consumption surveillance, GLASS-AMC, and summarizes the results of the 2020 AMR and AMC data calls. It also describes the status of development of GLASS activities and WHO AMR-related activities globally and regionally.

Framework for monitoring sexually transmitted infections and strengthening surveillance
Framework for monitoring sexually transmitted infections and strengthening surveillance

Author: World Health Organization

Publisher: World Health Organization

Published: 2024-07-18

Total Pages: 52

ISBN-13: 9240097678

DOWNLOAD EBOOK

This publication has been developed to provide a national framework for monitoring the health sector’s response to sexually transmitted infections and a set of core indicators to: -support countries monitor their programming for sexually transmitted infections and to identify gaps and challenges; and -facilitate regional and global tracking of the progress of WHO Member States in strengthening STI programming towards achieving the targets outlined in the global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections. The core indicators are structured around currently available STI interventions and data that are routinely collected or can be monitored at least annually. The indicators are aligned with global reporting requirements and to the targets detailed in the global health sector strategies. Collecting and analysing these data will provide a comprehensive picture of the health burden of STIs and will inform how best to allocate resources to improve the effectiveness, efficiency and equity of STI services. The publication also outlines a stepwise approach to strengthen the monitoring of STI programmes and STI surveillance.